What they were paid
Immunome Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $47,500 | $0 | $135,000 | $0 | $182,500 |
| FY2024 | $32,493 | — | $404,954 | — | $437,447 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immunome Inc. DEF 14A filed April 24, 2026, accession 0001140361-26-016685, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Immunome Inc. filed document, accession 0001140361-26-016685. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.
Get the Immunome Board Governance Report
$182,500 Sandra Swain, M.D, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 24, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Committees
FY2025 · as the proxy prints themAudit
The rest of the Immunome board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Carol Schafer | Independent Director | $195,000 |
| Clay Siegall, Ph.D | Chair of the Board | — |
| Isaac Barchas, J.D | Lead Independent Director | $210,000 |
| James Boylan | Independent Director | $190,000 |
| Jean-Jacques Bienaimé | Independent Director | $187,500 |
| Philip Wagenheim | Independent Director | $175,000 |
The full Immunome compensation record
free company briefThis page is one director within Immunome's record. The company brief lists every named executive and director, each linking to their own page.
Order IMNM
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.